This episode focuses on how IQVIA is innovating with agentic AI to drive efficiency and quality in clinical trials. 
 
In this episode you will:   

• Discover how agentic AI can be leveraged to enhance efficiency and quality in clinical trials and help increase the chance of success. 
• See how an agentic AI approach can optimize site selection, trial design, and other critical elements in clinical trials. 
• Learn about using agentic AI to identify new indications and targets in early clinical development by analyzing data from multiple databases. 

Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions.

This podcast features malaria experts Caroline Boulton (Global Program Head, Malaria, at Novartis); Sherwin Charles (CEO, Goodbye Malaria); and Carlos Chaccour (Researcher and Visiting Scholar, Navarra Institute for International Development). The conversation delves into the current malaria response, examining shifts in international funding, R&D innovations, drug resistance challenges, emerging prevention tools, and the impact of climate change.

The podcast is hosted by IQVIA’s Daniel Mora-Brito, Engagement Manager, Global Health, EMEA Thought Leadership.

In this episode, IQVIA MedTech experts Michelle Edwards and Michaela Miller discuss key trends shaping the MedTech industry in 2025. The conversation covers advancements in 3D printing, real-world evidence (RWE), and clinical AI, among others.
 
Read Ten MedTech Trends to Watch in 2025 to learn more.

Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA

Featured Speaker: Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIA

This podcast episode features a discussion between Jeff Pilch from IQVIA and Sanjay Mistry from Molnlycke. Together, they explore the journey of how their companies collaborated to solve a significant business problem related to customer master data management (MDM). Sanjay explains the challenges Molnlycke faced in defining and managing customer data across different units, which hindered their ability to perform basic analytics and customer segmentation. Jeff and Sanjay then discussed the solutions proposed by IQVIA, emphasizing a practical, incremental approach to implementing MDM and data governance, which helped Molnlycke achieve better data management and business efficiency.

Featured Speakers:

• Jeff Pilch - MDM Practice Lead, IQVIA 
• Sanjay Mistry - Director Data Operations, Commercial Excellence at Molnlycke

On International HPV Awareness Day, Dr. Nicola Paul hosts Dr. Tando Gaqana, a passionate HPV vaccine advocate, and Daniel Mora-Brito, IQVIA's thought leader in global health, to discuss the impact of Human Papillomavirus (HPV) in South Africa, highlighting the importance of vaccination and regular screening to prevent HPV-related conditions in Africa.

This episode focuses on using AI for indication selection and prioritization to optimize the value of clinical development planning. 

In this episode you will:  

• Discover how AI can identify indications with the greatest probability of success and areas of untapped opportunity. 
• See how AI can be leveraged to prioritize hundreds of indications into high-potential opportunities rapidly. 
• Learn about using AI to look at clinical trial data to help predict the future competitive intensity for an indication.  

Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions.

In this episode, Ekra Yao shares his view of the ongoing efforts and strategies in the fight against polio in Africa.

In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics shares her perspectives on the potential of GenAI to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks.

Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA

Featured Speaker: Vishakha Sharma, Ph.D., Senior Principal Data Scientist, Roche Diagnostics

Join IQVIA Thought Leaders, Kirstie Scott and Stefan Lutzmayer, to explore how to translate the promise of ground-breaking oncology therapies into commercially successful launches. Learn about the evolving oncology landscape, and how to navigate a fluid and challenging commercial environment to achieve Oncology Launch Excellence.

In this episode you will: 

• Discover how AI can predict the success of clinical trials in terms of efficacy, regulatory approval, operational feasibility, reimbursement attainment and product uptake. 
• Learn why AI can give us deeper insights by analyzing unstructured data for better-informed clinical development decisions. 
• See how an agentic AI approach can speed up what would take months and weeks manually, to days and hours, while looking at even more information for the analysis.   

Speaker: Raja Shankar, Vice President of Machine Learning in IQVIA’s Research and Development Solutions

Tune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how AI/ML-powered solutions are revolutionizing the pharmaceutical industry and providing actionable insights that drive better business results. Don't miss this insightful discussion!

IQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in the region, and the development and growth of the teams and the individuals.

Elyse Munoz, IQVIA’s US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it’s different from Europe), and direct-to-consumer advertising (prohibited in other major markets).

IQVIA's Vice President for Tech & Services in the Middle East, Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region, Pedro Matos Rosa about lung cancer in the region. Pedro and Rauf discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress in the fight against this cancer, and the need for more initiatives in the region to help fight against lung cancer.

In 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepatitis C to its successful elimination, and shares lessons and insights on how the strategy that was implemented can be adapted in other low- and middle-income countries.

In episode 8, IQVIA EMEA Thought Leaderships’ lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.

This podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in achieving it. He and OneKey’s Charles Wallace, Associate Director Product Offering, discusses the integration process, quantifiable metrics, and the benefits of using OneKey data. Listen to the podcast to learn about Smith and Nephew’s success story and how OneKey has streamlined their operations.

Featured speakers:

• Charles Wallace, OneKey Associate Director Product Offering, IQVIA
• Bob Forcier, Director, Smith and Nephew

Omnichannel is now a top priority for most pharma brand and commercial leaders. There’s a clear focus to embed omnichannel engagement and drive differentiating, consumer-like experiences within campaign plans and brand strategies. And while every organization is at a different maturity level, at IQVIA, we have seen a common trend that progress, regardless of your maturation, is harder and more limited than ever. 

In this podcast, IQVIA’s Matthew Smith and Matthew Doyle host a roundtable discussion with Takeda’s Chris Weber, Head of Customer Experience, U.S. Oncology, Julia Allen, Product Marketing Director, from Fresenius Medical Care, and Eisai’s Jared Shechtman, Marketing Technology Solutions, who share their unique perspectives on where the pharma industry currently stands with omnichannel transformations, the challenges related to execution, and what’s needed to be more successful in 2024 and beyond.

In today’s complex healthcare landscape, understanding your customers is more challenging than ever, and as such, medical device and diagnostic line partners face significant gaps and unmet needs for their commercial teams. IQVIA’s latest solution, the MedTech Market Activator, fueled with OneKey data, empowers commercial teams with comprehensive insights and tools to support strategic growth and daily activities. Tune in to this podcast to learn from data and product experts about how the MedTech Market Activator will provide your teams the agility needed to make a greater impact.

Featured Speakers:

• Shauntell Kelley, Director of OneKey Product and Strategy, IQVIA
• Kristin Brillant, Director and Product Owner of MedTech Market Activator, IQVIA MedTech
• Harry Tomaszewski, Solutions Specialist, IQVIA MedTech

In episode 2, we examine financial assistance or case management: What is a case management approach and the importance of looking at the whole patient journey. 

In this episode, we examine the needs of patients in the current health systems and the role and potential of patient support programs to improve patient access to reliable and innovative treatments.

Tune in as Paige Desmarais, IQVIA SFE Principal, and Ruoxin Li, IQVIA Sr Director in Advanced Analytics, delve into the transformative impact of AI and machine learning on healthcare analytics. In this episode, they explore how these technologies are reshaping provider referral patterns. As patient and provider journeys become increasingly complex, analytics managers and brand product managers seek innovative strategies to identify referral networks more effectively.

Clinical trials play a significant role in the development of drugs and medical breakthroughs. They are key for the advancement of medicine, although not all stakeholders are aware of their strong impact on patient care. Listen to our podcast with guest speaker Dr. Nawal Al-Kaabi, Senior Advisor and Consultant, Pediatric Infectious Disease at Sheikh Khalifa Medical City, who will walk us through the landscape of clinical trials in the UAE and the region, with a focus on the COVID-19 clinical trial program.

In this episode, Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care, discusses the importance of health equity and access to care in driving better health outcomes. Dr. Nash defines the issue of health equity and shares initiatives and opportunities for medical device and diagnostic companies to accelerate progress and address hurdles along the way. Key highlights include the challenges of data integration and interoperability.

Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA

Featured Speaker: Shelly Nash, DO, FACOOG, Senior Vice President, Global Chief Medical Information Officer, Fresenius Medical Care

IQVIA’s Vice President for Genomics and Precision Medicine Joanne Hackett discusses the importance of connected care, digital maturity, and innovation and technology in healthcare.

Learn about the progress and challenges facing the Expanded Program on Immunization in Nigeria.

In this episode, Sarah Rickwood and Stefan Lutzmayer discuss key findings from the “From Orphan to Opportunity: Mastering Rare Disease Launch Excellence” white paper. Discover how to navigate the complex rare disease landscape, overcome post-pandemic hurdles, and apply the three pillars of launch excellence to achieve success in rare diseases.

In this episode, IQVIA’s Raj Stewart and Michelle Edwards dig deeper into IQVIA’s annual “Ten MedTech Trends to Watch” report, which focuses on the key trends impacting the U.S. MedTech industry today. Learn how health equity, the consolidation of health systems, and advances in diagnostics are impacting the need for evidence generation among MedTech manufacturers and suppliers.

Read Ten MedTech Trends to Watch in 2024 to learn more.

Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIA

Featured Speakers: 

• Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIA
• Raj Stewart, Principal, MedTech Market Access, IQVIA

This episode focuses on Patient Centricity in Design and how engaging patients in protocol design can improve clinical outcomes. IQVIA’s Patient Centricity in Design solution helps sponsors optimize study design for patient engagement and patient outcomes, such as incorporating diverse patient preferences, selecting design elements that align with real-world patient experiences and using this knowledge to minimize patient burden. Ivan Petrov, Associate Design Analytics Director is our featured speaker.

Sarah Rickwood is joined by Elyse Muñoz, IQVIA’s US Director of Research & Insights, to discuss the first of a three-part launch excellence series on the current state of US launch and the new rules for launching excellently in the US, the most important market for global innovative medicines success.